
The Senior Director, Digital & AI Manufacturing, Supply Chain & Quality Transformation shapes Fresenius Kabi’s future Digital & AI agenda across these functions.
Partnering with senior TechOps, Supply Chain and Quality leaders across business units and global functions, the role defines the digital vision for operations beyond 2030: increasingly cloud-native, AI-first, data-driven and digitally enabled.
As TechOps leadership’s strategic Digital & AI partner, the role owns the Manufacturing, Supply Chain and Quality Trend Radar, continuously assessing emerging technologies, industry developments and disruptive innovations over a 3-5 year horizon. It translates trends into actionable recommendations on organizational implications and industry-leading practices.
The role provides end-to-end transparency of the TechOps Digital & AI portfolio as the primary reference for ongoing, planned and emerging initiatives. It identifies, prioritizes and sequences opportunities across Manufacturing, Supply Chain and Quality, guiding investment and recommending whether initiatives should continue, scale, evolve or stop based on strategic relevance, business value and scalability.
Working through an agile team of AI & Digital Innovation Acceleration Managers and Business Unit partners, the role translates business challenges and strategic ambitions into Digital & AI use cases. It guides innovation from strategic advisory and opportunity identification through proof-of-value pilots, providing investment and scaling recommendations and decision support.
With the Digital & AI Capability and Workforce Strategy & Engagement teams, the role strengthens digital capabilities, adoption and workforce transformation for AI-enabled operations. As an external ambassador, it represents Fresenius Kabi’s Digital & AI perspective in Manufacturing, Supply Chain and Quality forums, industry networks and strategic partnerships, aligned with Group and segment stakeholders.
Shape the Future of Manufacturing, Supply Chain & Quality
Trend Monitoring & Innovation Scouting
Digital Portfolio Ownership & Synergy Realization
Big Bets, Use Cases & Proof of Value
Lead Business Transformation

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint